Conor Stewart
Research expert covering health & pharmaceuticals in the UK & Europe
Get in touch with us now| Characteristic | Fentanyl | Fentanyl analogues | Non fentanyl opioids | Stimulants | Other psychoactive substances |
|---|---|---|---|---|---|
| 2016 | 52% | - | 59% | - | 69% |
| 2017 | 69% | - | 39% | - | 61% |
| 2018 | 70% | 10% | 46% | 56% | 46% |
| 2019 | 62% | 21% | 44% | 56% | 45% |
| 2020 | 81% | 14% | 30% | 63% | 46% |
| 2021 | 85% | 18% | 25% | 66% | 50% |
| 2022 | 82% | 22% | 26% | 66% | 51% |
| 2023 | 82% | 40% | 24% | 68% | 62% |
| 2024 | 74% | 46% | 27% | 70% | 66% |
The chart is not accessible to screen readers. Please switch to the table view to access the data.
Loading statistic...
Download
Source
Source
Release date
June 2025
More information
Region
Canada
Survey time period
2016 to 2024
Supplementary notes
* Categories not mutually exclusive.
Figures show apparent opioid toxicity death (AOTD): A death caused by intoxication/toxicity (poisoning) resulting from substance use, where one or more of the substances is an opioid, regardless of how it was obtained (e.g. illegally or through personal prescription). Other substances may also be involved. Adapted from Statistics Canada, Opioid- and Stimulant-related Harms in Canada, 2016 to 2024. This does not constitute an endorsement by Statistics Canada of this product.
Citation formats
